BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Treatment
23 results:

  • 1. TRIB2 regulates the expression of miR‑33a‑5p through the ERK/c‑Fos pathway to affect the imatinib resistance of chronic myeloid leukemia cells.
    Sun H; Li Y; Wang X; Zhou X; Rong S; Liang D; Sun G; Cao H; Sun H; Wang R; Yan Y; Xie S; Sun Y
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35302171
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Silencing of circTASP1 inhibits proliferation and induces apoptosis of acute myeloid leukaemia cells through modulating miR-515-5p/hmga2 axis.
    Lin Y; Huang Y; Liang C; Xie S; Xie A
    J Cell Mol Med; 2021 Aug; 25(15):7367-7380. PubMed ID: 34197029
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Leukocyte-Mimetic liposomes Penetrate Into Tumor Spheroids and Suppress Spheroid Growth by Encapsulated Doxorubicin.
    Fukuta T; Yoshimi S; Kogure K
    J Pharm Sci; 2021 Apr; 110(4):1701-1709. PubMed ID: 33129835
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA.
    Muenchow A; Weller S; Hinterleitner C; Malenke E; Bugl S; Wirths S; Müller MR; Schulze-Osthoff K; Aulitzky WE; Kopp HG; Essmann F
    Cell Death Dis; 2020 Aug; 11(8):701. PubMed ID: 32839432
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Development of DDS Actively to Overcome the Blood-brain Barrier in the Region of Ischemic Stroke].
    Fukuta T; Kogure K
    Yakugaku Zasshi; 2020; 140(8):1007-1012. PubMed ID: 32741858
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response.
    Ji W; Li L; Zhou S; Qiu L; Qian Z; Zhang H; Zhao P
    J Drug Target; 2020 Nov; 28(9):982-990. PubMed ID: 32379004
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Oncofetal hmga2 attenuates genotoxic damage induced by topoisomerase II target compounds through the regulation of local DNA topology.
    Ahmed SM; Dröge P
    Mol Oncol; 2019 Oct; 13(10):2062-2078. PubMed ID: 31271486
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.
    Dobrotkova V; Chlapek P; Jezova M; Adamkova K; Mazanek P; Sterba J; Veselska R
    PLoS One; 2019; 14(6):e0218269. PubMed ID: 31188873
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. hmga2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
    Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
    Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Leukocyte-mimetic liposomes possessing leukocyte membrane proteins pass through inflamed endothelial cell layer by regulating intercellular junctions.
    Fukuta T; Yoshimi S; Tanaka T; Kogure K
    Int J Pharm; 2019 May; 563():314-323. PubMed ID: 30978483
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate and BIX-01294 have different impact on epigenetics and senescence modulation in acute and chronic myeloid leukemia cells.
    Vitkeviciene A; Baksiene S; Borutinskaite V; Navakauskiene R
    Eur J Pharmacol; 2018 Nov; 838():32-40. PubMed ID: 30194939
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Vincristine-Loaded and sgc8-Modified liposome as a Potential Targeted Drug Delivery System for Treating Acute Lymphoblastic leukemia.
    Duan S; Yu Y; Lai C; Wang D; Wang Y; Xue D; Hu Z; Lu X
    J Biomed Nanotechnol; 2018 May; 14(5):910-921. PubMed ID: 29883561
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Enhanced expression of tumour suppressor RAR-β by DSPC nano-formulated lipo-ATRA in the lung of B16F10 cell-implanted C57BL6 mice and in A549 cells.
    Berlin Grace VM; Reji RM; Sundaram V
    Life Sci; 2017 Sep; 184():10-17. PubMed ID: 28694088
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. hmga2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
    Wu Z; Eguchi-Ishimae M; Yagi C; Iwabuki H; Gao W; Tauchi H; Inukai T; Sugita K; Ishii E; Eguchi M
    Br J Haematol; 2015 Dec; 171(5):818-29. PubMed ID: 26403224
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions.
    Pedeutour F; Maire G; Pierron A; Thomas DM; Garsed DW; Bianchini L; Duranton-Tanneur V; Cortes-Maurel A; Italiano A; Squire JA; Coindre JM
    Virchows Arch; 2012 Jul; 461(1):67-78. PubMed ID: 22678079
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Photochemically generated elemental selenium forms conjugates with serum proteins that are preferentially cytotoxic to leukemia and selected solid tumor cells.
    Daziano JP; Günther WH; Krieg M; Tsujino I; Miyagi K; Anderson GS; Sampson RW; Ostrowski MD; Muir SA; Bula RJ; Sieber F
    Photochem Photobiol; 2012; 88(2):448-60. PubMed ID: 22211823
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SUMOylation of hmga2: selective destabilization of promyelocytic leukemia protein via proteasome.
    Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK
    Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Huge brain abscess and invasive pulmonary disease by fungal infection during chemotherapy for infantile acute myeloid leukemia].
    Sato T; Suzuki D; Ichikawa M; Kaneda M; Nakagawa A; Kobayashi R; Ariga T
    Rinsho Ketsueki; 2007 Dec; 48(12):1549-54. PubMed ID: 18203515
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.
    Tsimberidou AM; Tirado-Gomez M; Andreeff M; O'Brien S; Kantarjian H; Keating M; Lopez-Berestein G; Estey E
    Leuk Lymphoma; 2006 Jun; 47(6):1062-8. PubMed ID: 16840198
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies.
    Tsimberidou AM; Estey E; Whitman GJ; Dryden MJ; Ratnam S; Pierce S; Faderl S; Giles F; Kantarjian HM; Garcia-Manero G
    Leuk Res; 2004 Sep; 28(9):991-4. PubMed ID: 15234578
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.